Letter to the Editor: Microbial metabolites and immune regulation in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease
World Journal of Gastroenterology · 14.08.2026 · 32 (30)
DOI: 10.3748/wjg.118010 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 14.08.2026. Verfasst von Zi-Ke Chen und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
This letter aims to engage in a constructive discussion of the review written by Sokal-Dembowska et al , published in the recent issue of the World Journal of Gastroenterology . The review systematically expounds the role of the gut microbiota in linking inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease. We commend the authors for integrating evidence on gut dysbiosis, barrier dysfunction, oxidative stress, and the gut-liver axis. Based on this, we further focus on two key aspects: first, the functional impact of metabolites derived from gut microbiota; second, the complex heterogeneity reflected in the balance between T helper cell 17 and regulatory T cells. Additionally, we explore the potential and challenges of targeting the interleukin (IL)-17/IL-23 axis for treatment. To more intuitively illustrate the complex interactions mentioned above, we provide a schematic diagram of immune-metabolic crosstalk. Finally, this article further discusses the clinical significance of these understandings for the development of precise treatment strategies.
Zitieren
APA
Chen, Z., Shi, M., Wu, Y., Zhao, J., & Wang, Y. (2026). Letter to the Editor: Microbial metabolites and immune regulation in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology, 32(30). https://doi.org/10.3748/wjg.118010
Vancouver
Chen Z, Shi M, Wu Y, Zhao J, Wang Y. Letter to the Editor: Microbial metabolites and immune regulation in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology. 2026;32(30). doi:10.3748/wjg.118010
BibTeX
@article{Chen2026,
author = {Chen, Zi-Ke and Shi, Min and Wu, Yuan-Bin and Zhao, Jia-Wei and Wang, Yu-Gang},
title = {Letter to the Editor: Microbial metabolites and immune regulation in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {30},
doi = {10.3748/wjg.118010}
}
EUVIMED